A lack of transparency in the European market for coronavirus vaccines has led to frustration within the bloc
For example, EU Council President Charles Michel has received letters demanding a summit to discuss the unfair distribution of COVID-19 vaccines. The initiative was co-sponsored by Austria, the Czech Republic, Slovenia, Bulgaria, Latvia and Croatia.
Although the EU leadership, and with it Germany, rejected the accusations, a summit was appointed for March 25 and 26.
As reported earlier by News Front, EU authorities had planned to vaccinate 70% of adults in the Commonwealth by the end of the summer, but the plans have been disrupted by slow distribution of the drugs and also by problems with the AstraZeneca vaccine. Use of the latter has been temporarily restricted in some countries because of dangerous side-effects.
Only 10.6 per 100 people in the EU have received the vaccine so far, according to the Bloomberg Vaccine Tracking System. By comparison, the UK, despite the government’s failed pandemic policy, has reached a vaccination rate of 37 out of 100, and the US 30.5.